Not Tagged
Not Tagged
['leusm']
#asco22 #leusm wei: mido with 7+3 leads to less foavrable outcomes in age 60+ vs younger pts. suggests we should possibly use other options such as aza/ven or aza/gilt which appear (not randomized) to have better median os. 
Assoc Professor, UCSF hematology/BMT. Translational researcher interested in leukemia, MDS, MRD, post-HCT relapse, GVHD, & immune recon. Photos: pyknosis (IG)